Back to Journals » OncoTargets and Therapy » Volume 10

Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents

Total article views   HTML views PDF downloads Totals
14,482 Dovepress* 11,475+ 1,171 12,646
PubMed Central* 3,007 526 3,533
Totals 14,482 1,697 16,179
*Since 5 October 2017
Total mentioned Facebook Delicious Reddit Twitter Others
1 0 0 0 0 1

View citations on PubMed Central and Google Scholar